Literature DB >> 18705694

Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27.

Ascel Samba-Louaka1, Jean-Philippe Nougayrède, Claude Watrin, Grégory Jubelin, Eric Oswald, Frédéric Taieb.   

Abstract

The cycle inhibiting factor (Cif) is a cyclomodulin produced by enteropathogenic and enterohemorrhagic Escherichia coli. Upon injection into the host cell by the bacterial type III secretion system, Cif inhibits the G2/M transition via sustained inhibition of the mitosis inducer CDK1 independently of the DNA damage response. In this study, we show that Cif induces not only G2, but also G1 cell cycle arrest depending on the stage of cells in the cell cycle during the infection. In various cell lines including differentiated and untransformed enterocytes, the cell cycle arrests are correlated with the accumulation of the cyclin-dependent kinase inhibitors p21(waf1/cip1) and p27(kip1). Cif-induced cyclin-dependent kinase inhibitor accumulation is independent of the p53 pathway but occurs through inhibition of their proteasome-mediated degradation. Our results provide a direct link between the mode of action of Cif and the host cell cycle control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18705694     DOI: 10.1111/j.1462-5822.2008.01224.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  37 in total

Review 1.  Bacteria and host interactions in the gut epithelial barrier.

Authors:  Hiroshi Ashida; Michinaga Ogawa; Minsoo Kim; Hitomi Mimuro; Chihiro Sasakawa
Journal:  Nat Chem Biol       Date:  2011-12-15       Impact factor: 15.040

2.  Disease and Carrier Isolates of Neisseria meningitidis Cause G1 Cell Cycle Arrest in Human Epithelial Cells.

Authors:  Michael von Papen; Wilhelm F Oosthuysen; Jérôme Becam; Heike Claus; Alexandra Schubert-Unkmeir
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

3.  A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle.

Authors:  Qing Yao; Jixin Cui; Yongqun Zhu; Guolun Wang; Liyan Hu; Chengzu Long; Ran Cao; Xinqi Liu; Niu Huang; She Chen; Liping Liu; Feng Shao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

4.  The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells.

Authors:  Ascel Samba-Louaka; Jean-Philippe Nougayrède; Claude Watrin; Eric Oswald; Frédéric Taieb
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

Review 5.  Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

6.  Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.

Authors:  Jennifer Lising Roxas; Katheryn Ryan; Gayatri Vedantam; V K Viswanathan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-06-05       Impact factor: 4.052

7.  Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats.

Authors:  Françoise Rul; Leila Ben-Yahia; Fatima Chegdani; Laura Wrzosek; Stéphane Thomas; Marie-Louise Noordine; Christophe Gitton; Claire Cherbuy; Philippe Langella; Muriel Thomas
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

Review 8.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

9.  Genetic reprogramming of host cells by bacterial pathogens.

Authors:  Guy Tran Van Nhieu; Laurence Arbibe
Journal:  F1000 Biol Rep       Date:  2009-10-29

10.  Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens.

Authors:  Grégory Jubelin; Carolina Varela Chavez; Frédéric Taieb; Mark J Banfield; Ascel Samba-Louaka; Rika Nobe; Jean-Philippe Nougayrède; Robert Zumbihl; Alain Givaudan; Jean-Michel Escoubas; Eric Oswald
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.